Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 261

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management

Kowalski, Richard, Post, Diane, Schneider, Mary C, Britz, Judith, Thomas, Judy, Deierhoi, Mark, Lobashevsky, Andrew, Redfield, Robert, Schweitzer, Eugene, Heredia, Alonso, Reardon, Elise, Davis, Charles, Bentlejewski, Carol, Fung, John, Shapiro, Ron, Zeevi, Adriana·2003·Clinical Transplantation

Abstract

Abstract: Each year, 55 000 organ transplants are performed worldwide. Cumulatively, the number of living organ recipients is now estimated to be over 300 000. Most of these transplant recipients will remain on immunosuppressive drugs for the remainder of their lives to prevent rejection episodes. Controlled doses of these drugs are required to prevent over‐medication, which may leave the patient susceptible to opportunistic infection and drug toxicity effects, or under‐dosing, which may lead to shortened graft survival because of rejection episodes. This paper describes the result of a multicenter study conducted at the Universities of Pittsburgh, Alabama and Maryland to evaluate an in vitro assay (Cylex TM Immune Cell Function Assay) for the measurement of global immune response in transplant patients receiving immunosuppressive therapy. The assay uses a whole blood sample to maintain the presence of the drug during incubation. Following overnight incubation of blood with phytohemagglutinin (PHA), CD4 cells are selected using paramagnetic particles coated with a monoclonal antibody to the CD4 epitope. The CD4‐positive cells are targeted as major immunosuppressive drugs are designed to specifically inhibit T‐cell activation which has been implicated in rejection. The data generated at these three sites were submitted in support of an Food and Drug Association (FDA) application for the use of this assay in the detection of cell‐mediated immunity in an immunosuppressed population. The assay was cleared by the FDA on April 2, 2002. This cross‐sectional study was designed to establish ranges for reactivity of this bioassay in the assessment of functional immunity for an individual solid organ recipient at any point in time.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1034/j.1399-0012.2003.00013.x

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 261

Metadata

Authors
Kowalski, R., Post, D., Schneider, M. C., Britz, J., Thomas, J., Deierhoi, M., Lobashevsky, A., Redfield, R., Schweitzer, E., Heredia, A., Reardon, E., Davis, C., Bentlejewski, C., Fung, J., Shapiro, R., & Zeevi, A.
Venue
Clinical Transplantation
Publisher
Wiley
Published
2003-04
Volume
17
Issue
2
Pages
77-88
ISSN
  • 0902-0063 (ISSN-L)
  • 1399-0012
OpenAlex
W2133372129
Cited by
261
References
10
FWCI
4.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. https://app.cochat.ai/papers/10.1034/j.1399-0012.2003.00013.x
The paper
Kowalski, R., Post, D., Schneider, M. C., Britz, J., Thomas, J., Deierhoi, M., Lobashevsky, A., Redfield, R., Schweitzer, E., Heredia, A., Reardon, E., Davis, C., Bentlejewski, C., Fung, J., Shapiro, R., & Zeevi, A. (2003). Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clinical Transplantation. https://doi.org/10.1034/j.1399-0012.2003.00013.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.